デフォルト表紙
市場調査レポート
商品コード
1428310

血管塞栓術の世界市場レポート 2024

Vascular Embolization Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血管塞栓術の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

血管塞栓術の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.8%の年間平均成長率(CAGR)で43億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、慢性疾患の症例の増加、研究開発活動への投資の増加、低侵襲処置への選好の高まり、地理的拡大とヘルスケアへのアクセスの改善、および可処分所得の増加に起因すると考えられます。予測期間中に予想される主な動向には、技術の進歩、戦略的コラボレーション、業界内の革新的な血管塞栓術デバイスの開発が含まれます。

血管疾患の有病率の予想される増加は、血管塞栓術市場の成長を促進すると予想されます。血管疾患には、動脈や静脈などの血管に影響を及ぼすさまざまな疾患が含まれ、末梢血管疾患、腹部大動脈瘤、深部静脈血栓症、アテローム性動脈硬化症、慢性静脈不全、末梢動脈疾患など、血流の低下やさまざまな状態が引き起こされます。 血管塞栓術は、出血に対処し、動脈瘤を修復し、静脈内の血液供給を強化するための血管の閉塞または閉塞を伴う、これらの疾患の治療として機能します。 2023年 4月の時点で、HMP Communications LLCは、2020年の末梢動脈疾患(PAD)の世界有病率は2,100万人であり、2030年までに2,380万人に達すると予測されていると報告しました。これは、血管疾患の有病率の増加が、いかに血管塞栓術市場の重要な推進力であるかを強調しています。

慢性腎臓病の有病率の高さも、血管塞栓術市場の成長に大きく寄与すると予想されます。慢性腎臓病(CKD)は、時間の経過とともに徐々に腎臓に不可逆的なダメージを与えます。 血管塞栓術は、腎臓腫瘍、動静脈奇形(AVM)、または腎生検や移植による合併症による出血を止めるためにCKDで使用されます。このアプローチにより、特に腎機能が低下した患者における開腹手術に伴うリスクが回避されます。特に、オーストラリアでは、2020年から2021年にかけて、約200万人の入院(総入院数の17%)がCKDに起因するとされており、この疾患の多大な影響が強調されています。慢性腎臓病の蔓延は、血管塞栓術市場の成長の原動力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の血管塞栓術市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 塞栓剤
  • 塞栓用デバイス
  • 世界の血管塞栓術市場、塞栓技術別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • コイリング装置
  • 非コイリング装置
  • 世界の血管塞栓術市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 末梢血管疾患
  • 腫瘍学
  • 泌尿器科
  • 神経内科
  • その他
  • 世界の血管塞栓術市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 専門クリニック
  • 外来手術センター
  • 診断センター

第7章 地域および国の分析

  • 世界の血管塞栓術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の血管塞栓術市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 血管塞栓術市場の競合情勢
  • 血管塞栓術市場の企業プロファイル
    • Johnson and Johnson Co
    • Abbott Laboratories
    • Medtronic Plc.
    • Merck Group
    • Stryker Corporation

第31章 その他の大手および革新的な企業

  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Kaneka Corporation
  • Terumo Corporation
  • WL Gore &Associates Inc.
  • Teleflex Inc.
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • MicroPort Scientific Corporation
  • MicroVention Inc.
  • Medikit Co Ltd.
  • Silk Road Medical Inc.
  • Galt Medical Corporation
  • Neuravi Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14154

Vascular embolization is a minimally invasive procedure that utilizes different materials, including coils, particles, or liquid agents, to block or impede blood vessels, thereby halting arterial bleeding. This technique is employed for various purposes, such as treating malignancies, shrinking vascular abnormalities, or redirecting blood flow.

The main products associated with vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials injected or placed in specific regions to block or occlude blood vessels, effectively treating various medical conditions. These agents are utilized in different procedures to address medical issues such as tumors, aneurysms, and arteriovenous malformations (AVMs). Various embolization techniques include coiling devices and non-coiling devices, applied in diverse medical applications such as peripheral vascular diseases, oncology, urology, neurology, and others. These products cater to various end-users, including hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

The vascular embolization market research report is one of a series of new reports from The Business Research Company that provides vascular embolization market statistics, including vascular embolization industry global market size, regional shares, competitors with a vascular embolization market share, detailed vascular embolization market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. This vascular embolization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular embolization market size has grown strongly in recent years. It will grow from $2.89 billion in 2023 to $3.13 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to the rising prevalence of vascular diseases, an increase in demand for non-coiling devices, a surge in the use of clot agents, and increased awareness about advanced treatment options for vascular conditions.

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period can be attributed to the growth in the cases of chronic diseases, increasing investments in R&D activities, a growing preference for minimally invasive procedures, geographic expansion and improved access to healthcare, and rising disposable incomes. Key trends expected in the forecast period include technological advancements, strategic collaborations, and the development of innovative vascular embolization devices within the industry.

The anticipated rise in the prevalence of vascular diseases is set to drive the growth of the vascular embolization market. Vascular diseases encompass various disorders affecting blood vessels, including arteries and veins, leading to reduced blood flow and various conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases. Vascular embolization serves as a treatment for these disorders, involving the occlusion or obstruction of blood vessels to address bleeding, repair aneurysms, and enhance blood supply in veins. As of April 2023, HMP Communications LLC reported a global prevalence of 21 million cases of peripheral artery diseases (PAD) in 2020, projected to reach 23.8 million by 2030. This underlines how the increasing prevalence of vascular diseases is a key driver for the vascular embolization market.

The high prevalence of chronic kidney diseases is also expected to contribute significantly to the growth of the vascular embolization market. Chronic Kidney Disease (CKD) involves gradual and irreversible damage to the kidneys over time. Vascular embolization is employed in CKD to halt bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications from kidney biopsies or transplants. This approach avoids the risks associated with open surgery, particularly in patients with compromised kidney function. Notably, in Australia, from 2020 to 2021, around 2 million hospitalizations (17% of total admissions) were attributed to CKD, emphasizing the considerable impact of this condition. The prevalence of chronic kidney diseases is a driving force behind the growth of the vascular embolization market.

A prominent trend in the vascular embolization market is the adoption of technological advancements by major companies. These innovations are geared towards sustaining their market positions and enhancing the effectiveness of vascular embolization procedures. For example, in June 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, introduced the Pipeline Vantage, a flex embolization device designed for the treatment of brain aneurysms. This device incorporates shield technology and features improved delivery design characteristics, making it more reliable for clinicians to transport, deploy, and treat brain aneurysms.

Major companies in the vascular embolization market are focusing on developing innovative products such as embolic systems to drive profitability. Embolic systems, comprising embolic agents and delivery devices, are utilized to intentionally block blood vessels in medical procedures. In October 2023, Sirtex Medical launched the Lava liquid embolic system (LES), offering a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small and hard-to-reach vessels, providing physicians with enhanced treatment options.

In August 2022, Boston Scientific Corporation acquired Obsidio. This acquisition aims to expand Boston Scientific Corporation's interventional oncology and embolization portfolio, offering unique options for physicians and patients dealing with hemorrhages, cancer, and other debilitating conditions. Obsidio specializes in minimally invasive blood vessel occlusion.

Major companies operating in the vascular embolization market report are Johnson and Johnson Co, Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

North America was the largest region in the vascular embolization market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vascular embolization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Embolization Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular embolization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular embolization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular embolization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Embolic Agents; Embolization Devices
  • 2) By Embolization Technique: Coiling Devices; Non-Coiling Devices
  • 3) By Application: Peripheral Vascular Diseases; Oncology; Urology; Neurology; Other Applications
  • 4) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Diagnostic Centers
  • Companies Mentioned: Johnson and Johnson Co; Abbott Laboratories; Medtronic Plc.; Merck Group; Stryker Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Embolization Market Characteristics

3. Vascular Embolization Market Trends And Strategies

4. Vascular Embolization Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Vascular Embolization Market Size and Growth

  • 5.1. Global Vascular Embolization Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Vascular Embolization Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Vascular Embolization Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vascular Embolization Market Segmentation

  • 6.1. Global Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Embolic Agents
  • Embolization Devices
  • 6.2. Global Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coiling Devices
  • Non-Coiling Devices
  • 6.3. Global Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Peripheral Vascular Diseases
  • Oncology
  • Urology
  • Neurology
  • Other Applications
  • 6.4. Global Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

7. Vascular Embolization Market Regional And Country Analysis

  • 7.1. Global Vascular Embolization Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Vascular Embolization Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vascular Embolization Market

  • 8.1. Asia-Pacific Vascular Embolization Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vascular Embolization Market

  • 9.1. China Vascular Embolization Market Overview
  • 9.2. China Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vascular Embolization Market

  • 10.1. India Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vascular Embolization Market

  • 11.1. Japan Vascular Embolization Market Overview
  • 11.2. Japan Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vascular Embolization Market

  • 12.1. Australia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vascular Embolization Market

  • 13.1. Indonesia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vascular Embolization Market

  • 14.1. South Korea Vascular Embolization Market Overview
  • 14.2. South Korea Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vascular Embolization Market

  • 15.1. Western Europe Vascular Embolization Market Overview
  • 15.2. Western Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vascular Embolization Market

  • 16.1. UK Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vascular Embolization Market

  • 17.1. Germany Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vascular Embolization Market

  • 18.1. France Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vascular Embolization Market

  • 19.1. Italy Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vascular Embolization Market

  • 20.1. Spain Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vascular Embolization Market

  • 21.1. Eastern Europe Vascular Embolization Market Overview
  • 21.2. Eastern Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vascular Embolization Market

  • 22.1. Russia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vascular Embolization Market

  • 23.1. North America Vascular Embolization Market Overview
  • 23.2. North America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vascular Embolization Market

  • 24.1. USA Vascular Embolization Market Overview
  • 24.2. USA Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vascular Embolization Market

  • 25.1. Canada Vascular Embolization Market Overview
  • 25.2. Canada Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vascular Embolization Market

  • 26.1. South America Vascular Embolization Market Overview
  • 26.2. South America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vascular Embolization Market

  • 27.1. Brazil Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vascular Embolization Market

  • 28.1. Middle East Vascular Embolization Market Overview
  • 28.2. Middle East Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vascular Embolization Market

  • 29.1. Africa Vascular Embolization Market Overview
  • 29.2. Africa Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vascular Embolization Market Competitive Landscape And Company Profiles

  • 30.1. Vascular Embolization Market Competitive Landscape
  • 30.2. Vascular Embolization Market Company Profiles
    • 30.2.1. Johnson and Johnson Co
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic Plc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck Group
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Stryker Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Vascular Embolization Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. B. Braun Melsungen AG
  • 31.3. Kaneka Corporation
  • 31.4. Terumo Corporation
  • 31.5. W. L. Gore & Associates Inc.
  • 31.6. Teleflex Inc.
  • 31.7. Cook Group Incorporated
  • 31.8. Merit Medical Systems Inc.
  • 31.9. Penumbra Inc.
  • 31.10. MicroPort Scientific Corporation
  • 31.11. MicroVention Inc.
  • 31.12. Medikit Co Ltd.
  • 31.13. Silk Road Medical Inc.
  • 31.14. Galt Medical Corporation
  • 31.15. Neuravi Ltd.

32. Global Vascular Embolization Market Competitive Benchmarking

33. Global Vascular Embolization Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Vascular Embolization Market

35. Vascular Embolization Market Future Outlook and Potential Analysis

  • 35.1 Vascular Embolization Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Vascular Embolization Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Vascular Embolization Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer